Apoptosis selectively induced in BEL-7402 cells by folic acid-modified magnetic nanoparticles combined with 100 Hz magnetic field

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2043-2050

  Wen, Jian ^a   Jiang, Shulian ^a   Chen, Zhiqiang ^a   Zhao, Wei ^a   Yi, Yongxiang ^a   Yang, Ruili ^a   Chen, Baoan ^b  

^a Nanjing Second Hospital   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Apoptosis; Extremely low frequency magnetic field; Folic acid; Liver cancer; Magnetic nanoparticle

Indexed keywords

FOLIC ACID; MAGNETIC NANOPARTICLE; ANTINEOPLASTIC AGENT; MAGNETITE NANOPARTICLE; NANOCAPSULE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG COATING; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG FORMULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IRON TRANSPORT; LIVER CANCER; MAGNETIC FIELD; MOLECULAR IMAGING; SCANNING ELECTRON MICROSCOPY; CHEMISTRY; CHEMORADIOTHERAPY; DRUG EFFECTS; MAGNETOTHERAPY; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; PROCEDURES; RADIATION RESPONSE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CHEMORADIOTHERAPY; FOLIC ACID; HUMANS; MAGNETIC FIELD THERAPY; MAGNETIC FIELDS; MAGNETITE NANOPARTICLES; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; TREATMENT OUTCOME;

EID: 84899656820     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S60457     Document Type: Article

References (22)

1. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294:1255-1259.
2. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5-S16.
3. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245-1255.
4. Ansary A, Faddah LM. Nanoparticles as biochemical sensors. Nanotechnol Sci Appl. 2010;3:65-76.
5. Wang J, Chen Y, Chen B, et al. Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in mice. Int J Nanomedicine. 2010;5:861-866.
6. Sonvico F, Mornet S, Vasseur S, et al. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug Chem. 2005;16:1181-1188.
7. Wu W, Chen B, Cheng J, et al. Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies. Int J Nanomedicine. 2010;5:1079-1084.
8. Repacholi MH, Greenebaum B. Interaction of static and extremely low frequency electric and magnetic fields with living systems: health effects and research needs. Bioelectromagnetics. 1999;20:133-160.
9. Chen ZQ, Wen J, Tu WY, Xiao L, Fang Z. A study on early apoptosis of hepatoma Bel-7402 cells in vitro treated by altering-electric magnetic field exposure of extremely low frequency combined with magnetic nano-Fe3O4 powders. Appl Mech Mater. 2013;364:742-748.
10. Hu S, Zhang Y. Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation. Int J Nanomedicine. 2010;5:1039-1048.
11. Bhattacharya R, Patra CR, Earl A, et al. Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells. Nanomedicine. 2007;3: 224-238.
12. Lowry MB, Duchemin AM, Robinson JM, Anderson CL. Functional separation of pseudopod extension and particle internalization during Fc gamma receptor-mediated phagocytosis. J Exp Med. 1998;187: 161-176.
13. Quintana A, Raczka E, Piehler L, et al. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res. 2002;19:1310-1316.
14. Moore A, Basilion JP, Chiocca EA, Weissleder R. Measuring t{stroke}ransferrin receptor gene expression by NMR imaging. Biochim Biophys Acta. 1998;1402:239-249.
15. Suzuki H, Toyooka T, Ibuki Y. Simple and easy method to evaluate uptake potential of nanoparticles in mammalian cells using a flow cytometric light scatter analysis. Environ Sci Technol. 2007;41: 3018-3024.
16. Saltan N, Kutlu HM, Hur D, Iscan A, Say R. Interaction of cancer cells with magnetic nanoparticles modified by methacrylamido-folic acid. Int J Nanomedicine. 2011;6:477-484.
17. Antony AC. The biology chemistry of folate receptors. Blood. 1992;79:2807-2820.
18. Yallapu MM, Othman SF, Curtis ET, et al. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomedicine. 2012;7:1761-1779.
19. Zhang J, Deng D, Qian Z, et al. The targeting behavior of folate-nanohydrogel evaluated by near infrared imaging system in tumor-bearing mouse models. Pharm Res. 2010;27:46-55.
20. Wiogo HT, Lim M, Bulmus V, Gutiérrez L, Woodward RC, Amal R. Insight into serum protein interactions with functionalized magnetic nanoparticles in biological media. Langmuir. 2012;28:4346-4356.
21. Pelkmans L, Helenius A. Endocytosis via caveolae. Traffic. 2002;3:311-320.
22. Huennekens FM, Vitols KS, Pope LE, Fan J. Membrane transport of folate compounds. J Nutr Sci Vitaminol (Tokyo). 1992;Spec No: 52-57.